BiotechTube
Home/Vincerx Pharma/Michael Morris, M.D.
MM

Michael Morris, M.D.

Chief Medical Officer

Vincerx Pharma

Therapeutic Areas

Oncology

Vincerx Pharma Pipeline

DrugIndicationPhase
VIP236Metastatic Solid TumorsPhase 1
VIP943Relapsed/Refractory Hematologic MalignanciesPhase 1
Enitociclib (VIP152)Non-Hodgkin Lymphoma (NHL)Phase 1
BCL-2 Inhibitor ProgramOncologyPreclinical

Leadership Team at Vincerx Pharma

AH
Ahmed Hamdy, M.D.
Chief Executive Officer
AC
Alexander C. Schmidt, Ph.D.
Chief Development Officer
JH
John H. Lee, M.D., Ph.D.
Former Chief Medical Officer
View full Vincerx Pharma profile